Xu Yang, Zalzala Munaf, Xu Jiesi, Li Yuanyuan, Yin Liya, Zhang Yanqiao
Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, Ohio 44272, USA.
Nat Commun. 2015 Jun 23;6:7466. doi: 10.1038/ncomms8466.
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases, but its underlying mechanism is poorly understood. Here we show that hepatocyte nuclear factor 4α (HNF4α), a liver-enriched nuclear hormone receptor, is markedly inhibited, whereas miR-34a is highly induced in patients with non-alcoholic steatohepatitis, diabetic mice and mice fed a high-fat diet. miR-34a is essential for HNF4α expression and regulates triglyceride accumulation in human and murine hepatocytes. miR-34a inhibits very low-density lipoprotein secretion and promotes liver steatosis and hypolipidemia in an HNF4α-dependent manner. As a result, increased miR-34a or reduced HNF4α expression in the liver attenuates the development of atherosclerosis in Apoe(-/-) or Ldlr(-/-) mice. These data indicate that the miR-34a-HNF4α pathway is activated under common conditions of metabolic stress and may have a role in the pathogenesis of NAFLD and in regulating plasma lipoprotein metabolism. Targeting this pathway may represent a novel approach for the treatment of NAFLD.
非酒精性脂肪性肝病(NAFLD)是最常见的肝脏疾病之一,但其潜在机制仍知之甚少。我们在此表明,在非酒精性脂肪性肝炎患者、糖尿病小鼠和高脂饮食喂养的小鼠中,肝脏富集的核激素受体肝细胞核因子4α(HNF4α)受到显著抑制,而miR-34a则被高度诱导。miR-34a对HNF4α的表达至关重要,并调节人和小鼠肝细胞中的甘油三酯积累。miR-34a以HNF4α依赖的方式抑制极低密度脂蛋白的分泌,并促进肝脏脂肪变性和低脂血症。因此,肝脏中miR-34a增加或HNF4α表达降低会减弱Apoe(-/-)或Ldlr(-/-)小鼠动脉粥样硬化的发展。这些数据表明,miR-34a-HNF4α通路在常见的代谢应激条件下被激活,可能在NAFLD的发病机制以及调节血浆脂蛋白代谢中发挥作用。针对该通路可能代表一种治疗NAFLD的新方法。